Latest Breaking News On - Alanh auerbach - Page 1 : vimarsana.com

Puma Biotechnology to Join Russell 3000 Index

Puma Biotechnology to Join Russell 3000 Index
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesAlanh auerbachExchange commissionDrug administrationEuropean commissionPuma biotechnology incPuma biotechnologyRussell investmentRussell indexesChief executive officerRussell globalLooking statementsAnnual report

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAlanh auerbachDrug administrationEuropean commissionCompensation committee of puma board directorsPuma biotechnology incCompensation committeeInducement incentive award planNasdaq listing rulePuma biotechnologyMariann ohanesian

Puma Biotechnology, Inc (NASDAQ:PBYI) Short Interest Down 18 6% in March

Puma Biotechnology, Inc (NASDAQ:PBYI) Short Interest Down 18 6% in March
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesMaximof nouguesAlanh auerbachMackenzie financial corpPuma biotechnology incPuma biotechnology company profileBalyasny asset managementPuma biotechnologyGet free reportStreet groupAsset managementFinancial corpBiotechnology trading downPuma biotechnology daily

Puma Biotechnology, Inc (NASDAQ:PBYI) Short Interest Update

Puma Biotechnology, Inc (NASDAQ:PBYI) Short Interest Update
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesAlanh auerbachMaximof nouguesSecurities exchange commissionMackenzie financial corpBalyasny asset managementPuma biotechnology incPuma biotechnologyGet free reportExchange commissionStreet groupAsset managementFinancial corpBiotechnology trading downPuma biotechnology daily

Puma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results

Puma Biotechnology, Inc. , a biopharmaceutical company, announced financial results for the fourth quarter and year ended December 31, 2023. Unless otherwise stated, all comparisons are for the.

United statesAlanh auerbachExchange commissionDrug administrationEuropean commissionDevelopment expensesPuma biotechnology incDevelopment expensePuma biotechnologyChief executive officerIn process researchFull yearNet adjustmentBiotechnology conference callPuma patient lynxFetal toxicity